Bicocca Open Archive

Logo unimib boa
FAZIO, FERRUCCIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.954
AS - Asia 20.263
EU - Europa 17.242
SA - Sud America 2.729
AF - Africa 369
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 29
Totale 85.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.418
SG - Singapore 7.281
CN - Cina 5.007
HK - Hong Kong 3.128
IT - Italia 2.850
SE - Svezia 2.689
RU - Federazione Russa 2.631
CA - Canada 2.336
UA - Ucraina 2.308
BR - Brasile 2.111
IE - Irlanda 2.036
VN - Vietnam 2.006
DE - Germania 1.828
GB - Regno Unito 941
FR - Francia 715
FI - Finlandia 586
BD - Bangladesh 573
IN - India 464
KR - Corea 384
AR - Argentina 255
TR - Turchia 219
NL - Olanda 205
IQ - Iraq 191
JP - Giappone 143
ZA - Sudafrica 131
PK - Pakistan 127
MX - Messico 112
EC - Ecuador 104
SA - Arabia Saudita 101
ID - Indonesia 91
PH - Filippine 85
PL - Polonia 81
UZ - Uzbekistan 68
CO - Colombia 66
ES - Italia 59
VE - Venezuela 59
MA - Marocco 50
MY - Malesia 50
BE - Belgio 49
AT - Austria 43
CL - Cile 41
TH - Thailandia 39
KE - Kenya 37
IR - Iran 35
PY - Paraguay 33
AE - Emirati Arabi Uniti 32
NP - Nepal 29
KZ - Kazakistan 28
ET - Etiopia 27
IL - Israele 27
PE - Perù 27
EU - Europa 26
TN - Tunisia 26
CH - Svizzera 23
DK - Danimarca 23
EG - Egitto 23
OM - Oman 22
RO - Romania 21
UY - Uruguay 20
DZ - Algeria 19
GR - Grecia 19
AZ - Azerbaigian 17
JM - Giamaica 17
JO - Giordania 17
LT - Lituania 17
PS - Palestinian Territory 16
PT - Portogallo 16
AU - Australia 15
BG - Bulgaria 13
CR - Costa Rica 13
CZ - Repubblica Ceca 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
AL - Albania 11
KW - Kuwait 11
LB - Libano 11
NZ - Nuova Zelanda 11
BH - Bahrain 9
KG - Kirghizistan 9
NG - Nigeria 9
TT - Trinidad e Tobago 9
BA - Bosnia-Erzegovina 8
HU - Ungheria 8
HN - Honduras 7
PA - Panama 7
RS - Serbia 7
AO - Angola 6
BY - Bielorussia 6
GE - Georgia 6
GT - Guatemala 6
LY - Libia 6
MK - Macedonia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
NI - Nicaragua 5
NO - Norvegia 5
EE - Estonia 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
Totale 85.526
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.865
Woodbridge 4.590
Singapore 3.910
Ashburn 3.532
Houston 3.464
Hong Kong 3.087
Fairfield 2.971
Jacksonville 2.562
Chandler 1.981
Dublin 1.919
Toronto 1.670
Dearborn 1.429
San Jose 1.285
Wilmington 1.176
Seattle 1.076
New York 1.028
Cambridge 975
Princeton 848
Milan 830
Frankfurt am Main 824
Santa Clara 824
Hefei 732
Chicago 655
The Dalles 651
Beijing 618
Ho Chi Minh City 563
Dallas 495
Nanjing 458
Hanoi 445
Lawrence 423
Lachine 421
Altamura 413
Los Angeles 384
Lauterbourg 371
Seoul 366
Shanghai 312
Moscow 285
Council Bluffs 255
Rome 228
Buffalo 205
San Diego 205
São Paulo 191
Shenyang 179
Boardman 159
Changsha 152
Nanchang 142
Huizen 136
Andover 135
Helsinki 135
Guangzhou 130
Munich 128
Hebei 120
Tianjin 111
Jiaxing 104
London 102
Dong Ket 100
Falls Church 97
Mountain View 93
Ottawa 92
Tokyo 84
Baghdad 79
Haiphong 77
Da Nang 76
Jinan 73
Zhengzhou 73
Salt Lake City 71
Philadelphia 61
Rio de Janeiro 60
Tashkent 57
Dhaka 54
Turin 53
University Park 52
Orem 51
Norwalk 50
Warsaw 49
Brooklyn 48
Ningbo 48
Phoenix 48
Columbus 47
Johannesburg 47
Hangzhou 46
Brussels 44
Chennai 44
Tampa 44
Jeddah 43
Nürnberg 42
Lahore 41
Elk Grove Village 40
Auburn Hills 39
Detroit 38
Montreal 38
Naples 38
Belo Horizonte 37
Curitiba 36
Montréal 36
Amsterdam 35
Brasília 35
Fremont 35
Quito 35
Atlanta 34
Totale 57.675
Salva come PNG Salva come JPEG
Nome #
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 526
Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy 499
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 464
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 458
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 455
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 453
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 410
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 394
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 365
Functional heterogeneity of left inferior frontal cortex as revealed by fMRI 359
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 358
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 351
Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: Assessment of tumor-related vascularization 346
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 333
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 329
11C-Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 324
Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy 322
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 320
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 319
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 317
Performance evaluation of the new whole-body PET/CT scanner: Discovery ST 317
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET 317
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 315
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 314
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 314
4D-PET data sorting into different number of phases: a NEMA IQ phantom study 312
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 311
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 310
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 310
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 307
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization 306
Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor 305
Left caloric vestibular stimulation ameliorates right hemianesthesia 299
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 298
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer 297
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 296
Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations 294
Acupuncture produces central activations in pain regions 290
Lesion detectability and quantification in PET/CT oncological studies by Monte Carlo simulations 288
Basal ganglia and language: Phonology modulates dopaminergic release 281
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 280
Localization of grasp representations in humans by PET: 1. Observation versus execution 280
A publicly accessible Monte Carlo database for validation purposes in emission tomography 274
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 273
Data rebinning and reconstruction in 3D PET/CT oncological studies: a Monte Carlo evaluation. 272
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 271
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 268
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: A cost-effectiveness analysis 267
Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report 265
PET and SPET molecular imaging: Focus on serotonin system 264
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 264
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 263
Supercalifragilisticexpialidocious: How the brain learns words never heard before 263
Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy 263
SPET imaging of cerebral perfusion in patients with non‐refractory temporal lobe epilepsy 262
Progressive dysphasic dementia with bucco-facial apraxia: A case report 262
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 261
A Monte Carlo model of noise components in 3-D PET 261
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 260
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 259
High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients 259
Evaluation of pre- and post-reconstruction count-dependent Metz filters for brain PET studies 257
Syntax and the brain: Disentangling grammar by selective anomalies 256
Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL). Lesioni mammarie non palpabili: la guida radiologica preoperatoria nella ROLL (radioguided occult lesion localisation) 256
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 255
The role of age of acquisition and language usage in early, high-proficient bilinguals: an fMRI study during verbal fluency 255
Isolated amnesia with slow onset and stable course, without ensuing dementia: MRI and PET data and a six-year neuropsychological follow-up 253
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 252
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 252
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [(18F)]fluorodeoxyglucose PET and CT comparison 251
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 251
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 248
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer 248
Metabolic impairment in human amnesia: a PET study of memory networks 248
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 247
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 247
Integrated CT/PET systems 247
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 247
An automatic classification technique for attenuation correction in positron emission tomography 246
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 246
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 246
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 246
A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical deconvolution 246
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 245
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 245
Head holder for PET, CT, and MR studies 245
Pathways of interhemispheric transfer in normals and in a split-brain subject. A positron emission tomography study 245
Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites 244
[(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy 243
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 243
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 242
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 242
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 242
Preserved functional competence of perilesional areas in drug-resistant epilepsy with lesion in supplementary motor cortex: fMRI and neuropsychological observations. 241
Remodelling of sensorimotor maps in paraplegia: a functional magnetic resonance imaging study after a surgical nerve transfer 240
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology 240
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder 240
Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography 240
Different brain correlates for watching real and virtual hand actions 240
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 240
Totale 28.991
Salva come PNG Salva come JPEG
Categoria #
all - tutte 282.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 282.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.752 186 478 767 563 272 238 218 263 263 271 414 819
2022/20237.521 1.043 2.344 421 658 580 1.234 98 330 499 34 207 73
2023/20244.881 163 159 171 145 780 1.374 1.055 122 464 21 46 381
2024/202510.645 717 1.586 405 456 951 270 340 499 1.200 1.360 917 1.944
2025/202626.650 2.073 1.952 2.089 2.601 2.520 1.530 3.377 1.592 2.274 1.985 2.444 2.213
2026/202760 60 0 0 0 0 0 0 0 0 0 0 0
Totale 85.999